Related content

Structure-activity relationships by mass spectrometry: identification of novel MMP-3 inhibitors

By Ockey D.A.   Dotson J.L.   Struble M.E.   Stults J.T.   Bourell J.H.   Clark K.R.   Gadek T.R.  

Bioorganic and Medicinal Chemistry, Vol. 12, Iss. 1, 2004-01 ,pp. : 37-44

Elsevier

Access to resources Recommend Favorite

A quantitative structure-activity relationship study for structurally diverse HIV-1 protease inhibitors: contribution of conformational flexibility to inhibitory activity

By Gohda Keigo  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 21, Iss. 5, 2006-10 ,pp. : 609-615

Informa Healthcare

Access to resources Recommend Favorite

Quantitative structure–activity relationships (QSARs) in CYP3A4 inhibitors: The importance of lipophilic character and hydrogen bonding

By Lewis David F.V.   Lake Brian G.   Dickins Maurice  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 21, Iss. 2, 2006-04 ,pp. : 127-132

Informa Healthcare

Access to resources Recommend Favorite

Lactoferrin and bone; structure–activity relationships

By Cornish J.   Palmano K.   Callon K.E.   Watson M.   Lin J.M.   Valenti P.   Naot D.   Grey A.B.   Reid I.R.  

Biochemistry and Cell Biology, Vol. 84, Iss. 3, 2006-06 ,pp. : 297-302

NRC Research Press

Access to resources Recommend Favorite

Structure–activity relationship study of copper(II) complexes with 2-oxo-1,2-dihydroquinoline-3-carbaldehyde (4′-methylbenzoyl) hydrazone: synthesis, structures, DNA and protein interaction studies, antioxidative and cytotoxic activity

By Senthil Raja Duraisamy   Bhuvanesh Nattamai   Natarajan Karuppannan  

JBIC Journal of Biological Inorganic Chemistry, Vol. 17, Iss. 2, 2012-02 ,pp. : 223-237

Springer Publishing Company

Access to resources Recommend Favorite